Weiner P, Gross D, Meiner Z, Ganem R, Weiner M, Zamir D, Rabner M
Department of Medicine A, Hillel Yaffe Medical Center, Hadera, Israel.
Can J Neurol Sci. 1998 Aug;25(3):236-41. doi: 10.1017/s0317167100034077.
Myasthenia gravis (MG) is a specific autoimmune disease characterized by weakness and fatigue. MG may affect also the respiratory muscles causing symptoms that may vary from dyspnea on severe exertion to dyspnea at rest. This study was undertaken in order to determine the effects of respiratory muscle training on respiratory muscle performance, spirometry data and the grade of dyspnea in patients with moderate to severe generalized MG.
Eighteen patients with MG were studied and divided into 2 groups: Group A included 10 patients (3 males and 7 females aged 29-68) with moderate MG, and Group B that included 8 patients (5 males and 3 females aged 21-74) with severe MG. Patients in Group A received both inspiratory and expiratory muscle training for 1/2 h/day, 6 times a week, for 3 months, while patients in Group B followed the same protocol but had inspiratory muscle training only.
Mean PImax increased significantly from 56.6 +/- 3.9 to 87.0 +/- 5.8 cm H2O (p < 0.001) in Group A, and from 28.9 +/- 5.9 to 45.5 +/- 6.7 cm H2O (p < 0.005) in Group B. The mean PEmax also increased significantly in patients in Group A, but remained unchanged in the patients in Group B. The respiratory muscle endurance also increased significantly, from 47.9 +/- 4.0 to 72.0 +/- 4.2%, p < 0.001, in patients of Group A, and from 26.0 +/- 2.9 to 43.4 +/- 3.8, p < 0.001, in patients in Group B. The improved respiratory muscle performance was associated with a significant increase in the FEV1 values, and in the FVC values, in patients of both groups. Mean dyspnea index score also increased significantly from 2.6 +/- 0.8 to 3.6 +/- 0.4 (p < 0.005) in Group A, and from 0.7 +/- 0.2 to 2.0 +/- 0.2 (p < 0.001) in Group B.
Specific inspiratory threshold loading training alone, or combined with specific expiratory training, markedly improved respiratory muscle strength and endurance in patients with MG. This improvement in respiratory muscle performance was associated with improved lung function and decreased dyspnea. Respiratory muscle training may prove useful as a complementary therapy with the aim of reducing dyspnea symptoms, delay the breathing crisis and the need for mechanical ventilation in patients with MG.
重症肌无力(MG)是一种以肌无力和疲劳为特征的特异性自身免疫性疾病。MG也可能影响呼吸肌,导致症状从剧烈运动时的呼吸困难到静息时的呼吸困难不等。本研究旨在确定呼吸肌训练对中重度全身型MG患者呼吸肌功能、肺功能数据和呼吸困难程度的影响。
对18例MG患者进行研究并分为2组:A组包括10例中度MG患者(3例男性,7例女性,年龄29 - 68岁),B组包括8例重度MG患者(5例男性,3例女性,年龄21 - 74岁)。A组患者接受吸气和呼气肌训练,每天1/2小时,每周6次,共3个月,而B组患者遵循相同方案,但仅进行吸气肌训练。
A组平均最大吸气压(PImax)从56.6±3.9显著增加至87.0±5.8 cmH₂O(p < 0.001),B组从28.9±5.9显著增加至45.5±6.7 cmH₂O(p < 0.005)。A组患者平均最大呼气压(PEmax)也显著增加,而B组患者保持不变。两组患者的呼吸肌耐力也显著增加,A组从47.9±4.0%增加至72.0±4.2%,p < 0.001,B组从26.0±2.9增加至43.4±3.8,p < 0.001。两组患者呼吸肌功能的改善与第一秒用力呼气容积(FEV1)值和用力肺活量(FVC)值的显著增加相关。A组平均呼吸困难指数评分也从2.6±0.8显著增加至3.6±0.4(p < 0.005),B组从0.7±0.2显著增加至2.0±0.2(p < 0.001)。
单独的特异性吸气阈值负荷训练或联合特异性呼气训练,可显著改善MG患者的呼吸肌力量和耐力。呼吸肌功能的这种改善与肺功能改善和呼吸困难减轻相关。呼吸肌训练可能作为一种辅助治疗手段,有助于减轻MG患者的呼吸困难症状,延缓呼吸危象及机械通气需求。